These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32557225)

  • 1. Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants.
    Luca Tiscia G; Colaizzo D; Vergura P; Favuzzi G; Chinni E; Vandermeulen C; Detemmerman L; Grandone E
    J Thromb Thrombolysis; 2020 Nov; 50(4):908-912. PubMed ID: 32557225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
    Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
    J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous allele-specific amplification: a strategy using modified primer-template mismatches for SNP detection--application to prothrombin 20210A (factor II) and factor V Leiden (1691A) gene mutations.
    DelRio-LaFreniere SA; McGlennen RC
    Mol Diagn; 2001 Sep; 6(3):201-9. PubMed ID: 11571714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.
    Rolla R; Pergolini P; Vidali M; Pollarolo P; Appiani A; Cerutti C; Manzini M; Crisci A; Bellomo G
    Clin Lab; 2014; 60(10):1725-33. PubMed ID: 25651720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
    Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test.
    Longshore JW; DeMartin K; Yu K; Das P; Zhang G; Rehage TT; Jethwaney D; Karwowska S
    J Thromb Thrombolysis; 2019 Jan; 47(1):87-95. PubMed ID: 30284176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible incorrect genotyping of heterozygous factor V Leiden and Prothrombin 20210 gene mutations by the GeneXpert assay.
    Marturano A; Bury L; Gresele P
    Clin Chim Acta; 2014 Aug; 435():36-9. PubMed ID: 24785585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.